company
Annora Pharma Private Limited
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-07-01Annora Pharma Private Limited — Class II recall: Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma…
Frequently asked questions
- How many FDA warning letters has Annora Pharma Private Limited received?
- Argus HQ has not recorded an FDA warning letter for Annora Pharma Private Limited in our current dataset.
- What FDA recalls has Annora Pharma Private Limited issued?
- Argus HQ has recorded 1 FDA recall tied to Annora Pharma Private Limited.
- Is Annora Pharma Private Limited FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 1 recall, and 0 approval records for Annora Pharma Private Limited. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

